Demant A/S Stock

Demant A/S EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Demant A/S (DEMANT.CO) as of Aug 9, 2026 is 10.40 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 14.52 % — a change of -28.39% (lower).

EBIT/Assets

10.40 %

YoY

-28.39%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Demant A/S is 2026 10.40 % . Operating Income to Assets Ratio (EBIT/Assets) of Demant A/S was 2025 14.52 % . It decreases by -28.39% lower compared to the previous year.
Access this data via the Eulerpool API

Demant A/S Stock analysis

What does Demant A/S do? Demant A/S is a Danish company that operates in the field of hearing technology. It was founded in 1904 and is headquartered in Smørum, Denmark. The company has several subsidiaries in various countries, including the USA, Germany, France, and China. The history of Demant began with the founding of the company Oticon by Hans Demant in Copenhagen in 1904. Oticon was the first company to manufacture and sell hearing aids. Since then, the company has evolved into a leading provider of hearing aids, cochlear implants, and assistive listening devices. Demant's business model is based on the development and marketing of hearing technology products. The company is divided into several business areas, including hearing aids, cochlear implants, and diagnostics and consumables. In the field of hearing aids, Demant offers a wide range of products tailored to the needs of different customer groups. These range from basic hearing aids to high-end products with artificial intelligence. Demant's cochlear implant system is a groundbreaking technology that enables deaf or hard-of-hearing individuals to hear. It consists of an implanted device and an external speech processor. Demant's diagnostics and consumables business includes a variety of products used by medical professionals for the diagnosis and treatment of hearing disorders. These include earplugs, audiometry devices, tympanometry devices, and others. Demant is also active in many other areas, including research, development, and production of hearing technology products. The company has a strong global network of partners, distributors, and customers that further strengthens its position as a leading provider of hearing technology products. Overall, Demant has developed a deep understanding of the needs and requirements of people with hearing problems through its commitment to excellence and innovation. With its wide range of products, global network, and deep commitment to customer satisfaction, Demant has become a trusted name in hearing technology. Demant A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Demant A/S stock

Operating Income to Assets Ratio (EBIT/Assets) of Demant A/S is 10.40 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Demant A/S changed from 14.52 % to 10.40 %, representing a -28.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Demant A/S since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Demant A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

Profitability — Demant A/S

All Key Metrics — Demant A/S